Home LiteratureArticle Details
PMID: 22031115 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

A missense mutation in PKD1 attenuates the severity of renal disease.

Kidney international ·Vol. 81 ·No. 4 ·2012-02-00 ·Pages 412-7

Pei Y, Lan Z, Wang K, Garcia-Gonzalez M, He N, Dicks E, Parfrey P, Germino G, Watnick T

Abstract

Mutations of PKD1 and PKD2 account for most cases of autosomal dominant polycystic kidney disease (ADPKD). Compared with PKD2, patients with PKD1 typically have more severe renal disease. Here, we report a follow-up study of a unique multigeneration family with bilineal ADPKD (NFL10) in which a PKD1 disease haplotype and a PKD2 (L736X) mutation co-segregated with 18 and 14 affected individuals, respectively. In our updated genotype-phenotype analysis of the family, we found that PKD1-affected individuals had uniformly mild renal disease similar to the PKD2-affected individuals. By sequencing all the exons and splice junctions of PKD1, we identified two missense mutations (Y528C and R1942H) from a PKD1-affected individual. Although both variants were predicted to be damaging to the mutant protein, only Y528C co-segregated with all of the PKD1-affected individuals in NFL10. Studies in MDCK cells stably expressing wild-type and mutant forms of PKD found that cell lines expressing the Y528C variant formed cysts in culture and displayed increased rates of growth and apoptosis. Thus, Y528C functions as a hypomorphic PKD1 allele. These findings have important implications for pathogenic mechanisms and molecular diagnostics of ADPKD.

MeSH Terms
Animals Apoptosis/genetics Cell Proliferation Cells, Cultured Cysts/genetics Dogs Genotype Humans Mutation, Missense Pedigree Phenotype Polycystic Kidney, Autosomal Dominant/genetics Severity of Illness Index TRPP Cation Channels/genetics
Chemicals
TRPP Cation Channels polycystic kidney disease 1 protein polycystic kidney disease 2 protein
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Pei York
Division of Nephrology, University of Toronto, Toronto, Ontario, Canada. york.pei@uhn.on.ca
Lan Zheng
Wang Kairong
Garcia-Gonzalez Miguel
He Ning
Dicks Elizabeth
Parfrey Patrick
Germino Gregory
Watnick Terry
References (28)
28 references, click to expand
  1. Diagnosis and screening of autosomal dominant polycystic kidney disease.
    Adv Chronic Kidney Dis. 2010 Mar;17(2):140-52 PMID: 20219617
  2. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.
    Cell. 1996 Dec 13;87(6):979-87 PMID: 8978603
  3. Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease.
    J Am Soc Nephrol. 1999 Jul;10(7):1524-9 PMID: 10405208
  4. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
    J Am Soc Nephrol. 2007 Jul;18(7):2143-60 PMID: 17582161
  5. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.
    Lancet. 1994 Apr 2;343(8901):824-7 PMID: 7908078
  6. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.
    Lancet. 1999 Jan 9;353(9147):103-7 PMID: 10023895
  7. Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.
    Am J Hum Genet. 2001 Feb;68(2):355-63 PMID: 11156533
  8. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations.
    Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16981-6 PMID: 12482949
  9. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
    J Am Soc Nephrol. 2006 Nov;17(11):3013-9 PMID: 17035604
  10. A complete mutation screen of the ADPKD genes by DHPLC.
    Kidney Int. 2002 May;61(5):1588-99 PMID: 11967008
  11. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.
    J Am Soc Nephrol. 2010 Jul;21(7):1097-102 PMID: 20558538
  12. Modifier genes play a significant role in the phenotypic expression of PKD1.
    Kidney Int. 2005 Apr;67(4):1256-67 PMID: 15780078
  13. Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples.
    J Am Soc Nephrol. 2001 May;12(5):955-963 PMID: 11316854
  14. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
    J Am Soc Nephrol. 2003 May;14(5):1164-74 PMID: 12707387
  15. Prediction of deleterious human alleles.
    Hum Mol Genet. 2001 Mar 15;10(6):591-7 PMID: 11230178
  16. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.
    Kidney Int. 2009 Apr;75(8):848-55 PMID: 19165178
  17. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.
    J Am Soc Nephrol. 2002 May;13(5):1230-7 PMID: 11961010
  18. Genetics and pathogenesis of polycystic kidney disease.
    J Am Soc Nephrol. 2002 Sep;13(9):2384-98 PMID: 12191984
  19. Assessing kidney function--measured and estimated glomerular filtration rate.
    N Engl J Med. 2006 Jun 8;354(23):2473-83 PMID: 16760447
  20. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells.
    Mol Cell. 2000 Nov;6(5):1267-73 PMID: 11106764
  21. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
    J Am Soc Nephrol. 2005 Mar;16(3):755-62 PMID: 15677307
  22. Somatic inactivation of Pkd2 results in polycystic kidney disease.
    Cell. 1998 Apr 17;93(2):177-88 PMID: 9568711
  23. Molecular pathogenesis of ADPKD: the polycystin complex gets complex.
    Kidney Int. 2005 Apr;67(4):1234-47 PMID: 15780076
  24. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
    Hum Mol Genet. 2004 Dec 15;13(24):3069-77 PMID: 15496422
  25. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.
    Mol Genet Metab. 2007 Sep-Oct;92(1-2):160-7 PMID: 17574468
  26. Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1.
    Am J Pathol. 2006 Jan;168(1):205-20 PMID: 16400024
  27. Genetic heterogeneity of polycystic kidney disease in Europe.
    Contrib Nephrol. 1992;97:128-39 PMID: 1633713
  28. Molecular diagnostics for autosomal dominant polycystic kidney disease.
    Nat Rev Nephrol. 2010 Apr;6(4):197-206 PMID: 20177400
Article Info
Journal
Kidney international
Abbr.
Kidney Int
ISSN
1523-1755
Published
2012-02-00
Epub
2011-00-26
Pages
412-7
Language
English
Region
United States
NLM ID
0323470
PMCID
PMC4105019
Subset
IM
Grants
NIGMS NIH HHS · R01 GM073704 · United States
Intramural NIH HHS · ZIA DK075042-03 · United States
NIDDK NIH HHS · DK48006 · United States
NIDDK NIH HHS · P30 DK090868 · United States
NIDDK NIH HHS · R01 DK076017 · United States
NIDDK NIH HHS · R01 DK048006 · United States
CIHR · MOP77806 · Canada
NIDDK NIH HHS · R37 DK048006 · United States
NIGMS NIH HHS · R01GM73704 · United States
NIDDK NIH HHS · R01DK0617 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com